Home

/

KETAMINE TREATMENT

Ketamine Treatment

Revolutionary therapy for depression, anxiety, and PTSD with 85% success rate and results in 24-72 hours

If you or family member struggle with depression, you are among the 16 million Americans who battle this medical condition every day. Of those who seek treatment, only a third find the answer.

Patients come in after spending years of seeing multiple doctors and being on a long list of different drugs without the results they want. Medications can stop working for some reason or the side effects are just not acceptable. Dr. Sambunaris is one of a handful of providers that provides ketamine for those looking for relief from depression, anxiety and PTSD.

Dr. Sambunaris has led over 200 medical research studies

Dr. Sambunaris has led over 200 medical research studies since his early days as a Clinical Staff Fellow at the National Institute of Mental Health (NIMH). It was his experience as a researcher in neuropharmacology that first sparked his interest in ketamine, a cutting-edge treatment option that works differently from traditional SSRIs like Prozac or Paxil or SNRIs like Effexor, Pristiq or Cymbalta – ironically all medications that he helped bring to market.

Many patients find their symptoms are lessened in just 24 to 72 hours—a huge improvement over the 6-12 week waiting period of other medications. Overall, ketamine’s success rate of 85% is almost double the 45% of traditional antidepressants.




200+

Research Studies




85%

Success Rate




24-72

Hours to Relief

Expert Ketamine Information from a World-Class Medical Researcher

Dr. Sambunaris brings decades of research experience from the National Institute of Mental Health (NIMH) to provide patients with the most advanced ketamine treatments available.

NIMH Clinical Fellow

Neuropharmacology Expert

200+ Research Studies

Ready to Start Your Journey to Mental Wellness?

Experience the breakthrough ketamine therapy that has helped thousands of patients find relief from depression, anxiety, and PTSD.